Background: p53 protein plays an important role in the response to DNA dama
ge, and radiotherapy can cause radiation dermatitis, p53 and p21 levels inc
rease in vitro when DNA is damaged by UVA, UVB, or gamma -radiation, To det
ermine whether this response occurs in human skin and predicts the level of
radiation dermatitis, we investigated levels of p53 and p21 in skin expose
d to different types of radiation as part of a randomized study of women wi
th breast cancer to evaluate topical steroid or emollient cream treatments
for radiation dermatitis of their irradiated breast. Methods: After surgery
but before receiving tangential 5-mV photo-beam radiotherapy (2 Gy and 54
Gy) to the affected breast parenchyma, multiple areas on the backs of 50 wo
men were irradiated with UVA and other areas were irradiated with UVB, Skin
biopsy samples were taken from areas of normal unirradiated skin and all i
rradiated areas, and p53 and p21 were detected immunohistochemically, All s
tatistical tests are two-sided. Results: In skin irradiated with UVA or UVB
, medians of 4.4% (range = 0%-40.5%) or 45.5% (range = 5.3%-74.6%) p53-posi
tive keratinocytes, respectively, were observed. Radiotherapy produced medi
ans of 31.0% (range = 0%-79.3%) p53-immunoreactive cells after 2 Gy of radi
ation and 83.2% (range = 37.6%-95.2%) after 54 Gy of radiation. Despite lar
ge interindividual differences in p53 response, comparable increases in epi
dermal p53 response were independent of the type of radiation. A correlatio
n between p53 and p21 was also evident (r(s) = .78), In breast skin, there
was no association between the p53 response and the degree of erythema (a m
easure of radiation dermatitis) and no statistically significant difference
between treatment arms and p21/p53 responses. Conclusions: Individual resp
onses to radiation-induced DNA damage varied widely and may be independent
of the type of radiation. The epidermal p53 response does not predict the d
egree of radiation dermatitis.